Data / Form D filings / Wenzel Spine, Inc.
Wenzel Spine, Inc.: Form D filings
Wenzel Spine, Inc., a biotechnology company in Austin, TX, filed 4 Form D notices with the SEC between 2009 and 2021. The latest, on November 10, 2021, reports $500,000 sold of a $1.5 million offering to 1 investor.
Find out what Wenzel Spine, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1130 RUTHERFORD LANE, SUITE 200, Austin, TX, 78753
- Phone
- (512) 469-0600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1475847
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2021 | New notice | $1,500,000 | $500,000 | $1,000,000 | 1 | Nov 3, 2021 | sec.gov |
| Jan 30, 2019 | New notice | $3,499,789 | $1,000,000 | $2,499,789 | 1 | Jan 11, 2019 | sec.gov |
| Jan 19, 2017 | New notice | $3,000,000 | $1,600,000 | $1,400,000 | 8 | Jan 17, 2017 | sec.gov |
| Nov 16, 2009 | New notice | $2,500,000 | $1,800,000 | $700,000 | 6 | Oct 29, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Warren Neely | Director | |
| Phillip Hodges | Director | |
| William Wilson | Executive Officer | |
| Philip Sanger | Director | |
| Chad Neely | Executive Officer, Director | |
| Anthony Lacenere | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Nov 8, 2021 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Wenzel Spine, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.